NM_004484.4:c.913G>A
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4
The NM_004484.4(GPC3):c.913G>A(p.Glu305Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000913 in 1,095,325 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E305A) has been classified as Uncertain significance.
Frequency
Consequence
NM_004484.4 missense
Scores
Clinical Significance
Conservation
Publications
- Simpson-Golabi-Behmel syndromeInheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- Simpson-Golabi-Behmel syndrome type 1Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_004484.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GPC3 | NM_004484.4 | MANE Select | c.913G>A | p.Glu305Lys | missense | Exon 3 of 8 | NP_004475.1 | ||
| GPC3 | NM_001164617.2 | c.913G>A | p.Glu305Lys | missense | Exon 3 of 9 | NP_001158089.1 | |||
| GPC3 | NM_001164618.2 | c.865G>A | p.Glu289Lys | missense | Exon 3 of 8 | NP_001158090.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GPC3 | ENST00000370818.8 | TSL:1 MANE Select | c.913G>A | p.Glu305Lys | missense | Exon 3 of 8 | ENSP00000359854.3 | ||
| GPC3 | ENST00000394299.7 | TSL:1 | c.913G>A | p.Glu305Lys | missense | Exon 3 of 9 | ENSP00000377836.2 | ||
| GPC3 | ENST00000631057.2 | TSL:1 | c.751G>A | p.Glu251Lys | missense | Exon 2 of 7 | ENSP00000486325.1 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome AF: 9.13e-7 AC: 1AN: 1095325Hom.: 0 Cov.: 32 AF XY: 0.00000277 AC XY: 1AN XY: 360751 show subpopulations
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
Wilms tumor 1 Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature in individuals affected with GPC3-related conditions. ClinVar contains an entry for this variant (Variation ID: 575501). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant is not present in population databases (ExAC no frequency). This sequence change replaces glutamic acid with lysine at codon 305 of the GPC3 protein (p.Glu305Lys). The glutamic acid residue is moderately conserved and there is a small physicochemical difference between glutamic acid and lysine.
Simpson-Golabi-Behmel syndrome type 1;CN033288:Wilms tumor 1 Uncertain:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at